GT Biopharma, Inc.
GTBP
$5.98
$0.7414.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.41% | 31.01% | 169.42% | -51.64% | 121.06% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -44.50% | -27.87% | -39.68% | -9.88% | 421.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -9.49% | -8.79% | -14.65% | 0.00% | 817.20% |
| Total Current Assets | -42.10% | 23.32% | 87.60% | -39.35% | 168.02% |
|
|
|||||
| Total Current Assets | -42.10% | 23.32% | 87.60% | -39.35% | 168.02% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -42.10% | 23.32% | 87.60% | -39.35% | 168.02% |
|
|
|||||
| Total Accounts Payable | 301.58% | -66.18% | -2.73% | -44.03% | -42.27% |
| Total Accrued Expenses | -44.38% | 38.65% | 290.00% | -34.21% | -46.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -92.76% | -53.23% | 157.94% |
| Total Other Current Liabilities | -- | -- | -92.76% | -53.23% | 157.94% |
| Total Current Liabilities | -8.15% | 4.18% | 75.55% | -42.74% | -36.59% |
|
|
|||||
| Total Current Liabilities | -8.15% | 4.18% | 75.55% | -42.74% | -36.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.15% | 4.18% | 75.55% | -42.74% | -36.59% |
|
|
|||||
| Common Stock & APIC | 0.08% | 0.65% | 3.68% | 0.49% | 0.77% |
| Retained Earnings | -0.63% | -0.41% | -3.30% | -0.47% | -0.22% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -52.92% | 30.99% | 92.93% | 4.86% | 391.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -99.95% | 195,600.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -99.95% | 195,600.00% |
|
|
|||||
| Total Common Equity | -52.92% | 30.99% | 92.93% | 4.86% | 391.54% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -99.95% | 195,600.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -52.92% | 30.98% | 92.90% | -37.72% | 591.53% |
|
|
|||||